Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-30 18:59:15 - browse：232

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Hospitals are piloting generative AI tools as regulators play catch

WSS

CommonSpirit Health keeps growing, even as it loses money

Congress may force more Covid

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Emergency workers more likely to restrain Black patients: study

Readout LOUD podcast: possible new ALS drug, artificial wombs

Experts study whether long Covid risk adds up with each reinfection

Wikipedia

Wikipedia

knowledge

23andMe had bad news about my health. I wish a person had delivered it

Opioid cravings were reduced by anti

Duchenne breakthrough therapy leaves behind pioneering families

Researchers tackle phage therapy hurdles for wider adoption

Jerome Adams on the need for new antivirals for Covid

A new drug could help frostbite victims avoid its ravages

Peter Hotez and the public health issue of online harassment

How Vertex's cystic fibrosis drug is changing patients' lives

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

entertainment

Researchers tackle phage therapy hurdles for wider adoption

How AI helped researchers track recovery from depression

Intarcia’s device

Senators: Long

FDA panel to weigh approval of NurOwn, controversial ALS drug

In 'major milestone,' FDA approves first cell therapy for solid tumors

explore

hotspot

entertainment

hotspot